Bakris G - Search Results

1

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Among authors: bakris g. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.

2

Treatment of hypertension in patients with renal disease.

Garg J, Bakris GL. Garg J, et al. Cardiovasc Drugs Ther. 2002 Dec;16(6):503-10. doi: 10.1023/a:1022973928505. Cardiovasc Drugs Ther. 2002. PMID: 12766383 Review.

3

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R. Eknoyan G, et al. Among authors: bakris gl. Am J Kidney Dis. 2003 Oct;42(4):617-22. doi: 10.1016/s0272-6386(03)00826-6. Am J Kidney Dis. 2003. PMID: 14520612 Review. No abstract available.

4

The role of calcium antagonists in chronic kidney disease.

Gashti CN, Bakris GL. Gashti CN, et al. Curr Opin Nephrol Hypertens. 2004 Mar;13(2):155-61. doi: 10.1097/00041552-200403000-00003. Curr Opin Nephrol Hypertens. 2004. PMID: 15202609 Review.

5

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.

Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Levin A, et al. Among authors: bakris gl. Kidney Int. 2007 Jan;71(1):31-8. doi: 10.1038/sj.ki.5002009. Epub 2006 Nov 8. Kidney Int. 2007. PMID: 17091124 Free article.

6

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL; KEEP Investigators. McCullough PA, et al. Arch Intern Med. 2007 Jun 11;167(11):1122-9. doi: 10.1001/archinte.167.11.1122. Arch Intern Med. 2007. PMID: 17563019

7

Cardiometabolic syndrome and chronic kidney disease: what is the link?

Sarafidis PA, Whaley-Connell A, Sowers JR, Bakris GL. Sarafidis PA, et al. J Cardiometab Syndr. 2006 Winter;1(1):58-65. doi: 10.1111/j.0197-3118.2006.05470.x. J Cardiometab Syndr. 2006. PMID: 17675896 Review.

8

Obesity and insulin resistance as risk factors for chronic kidney disease.

Whaley-Connell A, Pavey BS, Afroze A, Bakris GL. Whaley-Connell A, et al. J Cardiometab Syndr. 2006 Summer;1(3):209-14; quiz 215-6. doi: 10.1111/j.1559-4564.2006.05631.x. J Cardiometab Syndr. 2006. PMID: 17679819 Review.

9

Should beta-blockers be used to control hypertension in people with chronic kidney disease?

Hart PD, Bakris GL. Hart PD, et al. Semin Nephrol. 2007 Sep;27(5):555-64. doi: 10.1016/j.semnephrol.2007.07.003. Semin Nephrol. 2007. PMID: 17868793 Review.

10

Renin-angiotensin blockade and kidney disease.

Sarafidis PA, Bakris GL. Sarafidis PA, et al. Lancet. 2008 Aug 16;372(9638):511-2. doi: 10.1016/S0140-6736(08)61212-X. Lancet. 2008. PMID: 18707969 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,024 results

Search Page